- Home
- ECOR vs OMGA Comparison
ECOR vs OMGA Comparison
Compare ECOR & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- OMGA
- Stock Information
- Founded
- ECOR 2005
- OMGA 2017
- Country
- ECOR United States
- OMGA United States
- Employees
- ECOR N/A
- OMGA N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- ECOR Health Care
- OMGA Health Care
- Exchange
- ECOR Nasdaq
- OMGA Nasdaq
- Market Cap
- ECOR 87.1M
- OMGA 74.5M
- IPO Year
- ECOR 2018
- OMGA 2021
- Fundamental
- Price
- ECOR $10.94
- OMGA $0.82
- Analyst Decision
- ECOR Strong Buy
- OMGA Strong Buy
- Analyst Count
- ECOR 1
- OMGA 5
- Target Price
- ECOR $15.00
- OMGA $9.20
- AVG Volume (30 Days)
- ECOR 157.1K
- OMGA 450.6K
- Earning Date
- ECOR 11-13-2024
- OMGA 11-14-2024
- Dividend Yield
- ECOR N/A
- OMGA N/A
- EPS Growth
- ECOR N/A
- OMGA N/A
- EPS
- ECOR N/A
- OMGA N/A
- Revenue
- ECOR $23,327,000.00
- OMGA $8,095,000.00
- Revenue This Year
- ECOR $62.51
- OMGA $127.25
- Revenue Next Year
- ECOR $31.32
- OMGA N/A
- P/E Ratio
- ECOR N/A
- OMGA N/A
- Revenue Growth
- ECOR 74.10
- OMGA 185.04
- 52 Week Low
- ECOR $5.02
- OMGA $0.77
- 52 Week High
- ECOR $14.20
- OMGA $6.30
- Technical
- Relative Strength Index (RSI)
- ECOR 49.51
- OMGA 36.06
- Support Level
- ECOR $10.40
- OMGA $1.06
- Resistance Level
- ECOR $14.20
- OMGA $1.17
- Average True Range (ATR)
- ECOR 1.25
- OMGA 0.11
- MACD
- ECOR -0.14
- OMGA -0.02
- Stochastic Oscillator
- ECOR 14.21
- OMGA 2.25
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.